title: Platelet-Derived Growth Factor in the Ovarian Follicle Attracts the Stromal Cells of the Fallopian Tube Fimbriae.
abstract: During human ovulation, the fallopian tube fimbriae must move to the ovulation site to catch the oocyte. As the tissue-of-origin of the majority of ovarian high-grade serous carcinoma (HGSC), the fallopian tube fimbriae carrying a precursor cancer lesion may also approach the ovulatory site for metastasis. We hypothesize that platelet-derived growth factor (PDGF) in mature follicle fluid (FF) attracts the migration of PDGFR-expressing fimbriae toward the ovulating follicle. We observed that more PDGFR-β was expressed in the distal part than in the proximal parts of the fallopian tube, particularly in stromal cells in the lamina propria. The stromal cells, but not the epithelial cells, from normal fimbriae and fallopian tube HGSC were highly chemotactic to mature FF. The chemotactic activities were positively correlated with PDGF-BB and estradiol levels in FF and were abolished by a blocking antibody of PDGFR-β and by tyrosine kinase inhibitor imatinib. When PDGF-BB/AB was depleted from the FF, more than 80% of chemotaxis activities were diminished. This study suggests an ovarian follicle-directed and PDGF-dependent attraction of fallopian tube fimbriae before ovulation. The same mechanism may also be crucial for the ovarian homing of HGSC, which largely originates in the fimbriae.
authors.affiliation: Cervical Cancer Prevention Center, Tzu Chi General Hospital, Hualien, Hualien, 970, Taiwan, ROC.
authors.forename: Ching-Hua
authors.initials: CH
authors.lastname: Yeh
authors.affiliation: Department of Obstetrics and Gynecology,Tzu Chi General Hospital, Hualien, Hualien, 970, Taiwan, ROC.|Institute of Medical Sciences, Tzu Chi University, Hualien, 970, Taiwan, ROC.
authors.forename: Pao-Chu
authors.initials: PC
authors.lastname: Chen
authors.affiliation: Cervical Cancer Prevention Center, Tzu Chi General Hospital, Hualien, Hualien, 970, Taiwan, ROC.
authors.forename: Chiu-Hua
authors.initials: CH
authors.lastname: Chen
authors.affiliation: Cervical Cancer Prevention Center, Tzu Chi General Hospital, Hualien, Hualien, 970, Taiwan, ROC.
authors.forename: Che-Fang
authors.initials: CF
authors.lastname: Hsu
authors.affiliation: Department of Obstetrics and Gynecology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City, Taiwan, ROC.
authors.forename: Rui-Len
authors.initials: RL
authors.lastname: Huang
authors.affiliation: Cervical Cancer Prevention Center, Tzu Chi General Hospital, Hualien, Hualien, 970, Taiwan, ROC.
authors.forename: Dah-Ching
authors.initials: DC
authors.lastname: Ding
authors.affiliation: Cervical Cancer Prevention Center, Tzu Chi General Hospital, Hualien, Hualien, 970, Taiwan, ROC.|Department of Obstetrics and Gynecology,Tzu Chi General Hospital, Hualien, Hualien, 970, Taiwan, ROC.|Institute of Medical Sciences, Tzu Chi University, Hualien, 970, Taiwan, ROC.
authors.forename: Tang-Yuan
authors.initials: TY
authors.lastname: Chu
mesh_terms: D000328:Adult; D000368:Aged; D000077214:Becaplermin; D015153:Blotting, Western; D000072645:Cancer-Associated Fibroblasts / Q000378:metabolism; D002478:Cells, Cultured; D002633:Chemotaxis / Q000502:physiology; D018284:Cystadenocarcinoma, Serous / Q000378:metabolism / Q000473:pathology; D004958:Estradiol / Q000378:metabolism; D005187:Fallopian Tubes / Q000378:metabolism*; D005260:Female; D005434:Flow Cytometry; D015571:Follicular Fluid / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D006080:Ovarian Follicle / Q000378:metabolism*; D010051:Ovarian Neoplasms / Q000378:metabolism / Q000473:pathology; D010060:Ovulation / Q000502:physiology; D010982:Platelet-Derived Growth Factor / Q000378:metabolism*; D020574:Proto-Oncogene Proteins c-sis / Q000378:metabolism; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000378:metabolism; D017154:Stromal Cells / Q000378:metabolism*
chemical_list: D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D000077214:Becaplermin; D004958:Estradiol; D020797:Receptor, Platelet-Derived Growth Factor beta